ProCE Banner Activity

Histology-Agnostic Biomarkers in GI Malignancies

Slideset Download
Download this slideset for expert perspectives on best practices in testing for MSI/MMR, TMB, PD-L1, and NTRK fusions and using immune checkpoint and TRK inhibitors for patients with GI cancers.

Released: July 15, 2021

Expiration: July 14, 2022

No longer available for credit.

Share

Faculty

John L. Marshall

John L. Marshall, MD

Associate Professor, Hematology/Oncology
Department of Medicine
Georgetown University Hospital
Washington, DC

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Daiichi Sankyo, Inc.

Merck Sharp & Dohme Corp.

Faculty Disclosure

Primary Author

John L. Marshall, MD

Associate Professor, Hematology/Oncology
Department of Medicine
Georgetown University Hospital
Washington, DC